Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Invested Capital (2016 - 2025)

Medifast (MED) has disclosed Return on Invested Capital for 15 consecutive years, with 0.23% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Invested Capital fell 24.0% year-over-year to 0.23%, compared with a TTM value of 0.23% through Dec 2025, down 24.0%, and an annual FY2025 reading of 0.23%, down 24.0% over the prior year.
  • Return on Invested Capital was 0.23% for Q4 2025 at Medifast, down from 0.0% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.99% in Q3 2022 and bottomed at 0.23% in Q4 2025.
  • Average Return on Invested Capital over 5 years is 0.5%, with a median of 0.69% recorded in 2023.
  • The sharpest move saw Return on Invested Capital grew 22bps in 2021, then crashed -62bps in 2024.
  • Year by year, Return on Invested Capital stood at 0.82% in 2021, then rose by 15bps to 0.94% in 2022, then crashed by -48bps to 0.49% in 2023, then plummeted by -98bps to 0.01% in 2024, then plummeted by -3063bps to 0.23% in 2025.
  • Business Quant data shows Return on Invested Capital for MED at 0.23% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.